Jour : 10 mai 2018

A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti‐HERV‐W‐Env monoclonal antibody

Diabetes, Obesity and Metabolism, May 10, 2018 https://onlinelibrary.wiley.com/doi/10.1111/dom.13357